Analysis of the Bactericidal Response to an Experimental Neisseria meningitidis Vesicle Vaccine
Open Access
- 29 March 2012
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (5) , 659-665
- https://doi.org/10.1128/cvi.00070-12
Abstract
Rabbit immunogenicity studies on an experimental trivalent native outer membrane vesicle vaccine derived from three serogroup B strains were conducted to evaluate the effectiveness of this vaccine at inducing an antibody response with serum bactericidal activity against meningococcal strains of other serogroups in addition to serogroup B strains. The results showed that the vaccine was capable of inducing an effective broad-based bactericidal antibody response in rabbits against a small sample ofNeisseria meningitidisstrains of serogroups C, W135, and X and, to a lesser extent, serogroups A and Y. Analysis of antibody specificity using a bactericidal depletion assay revealed that antibodies to lipooligosaccharide (LOS), PorA, and NadA induced in rabbits by the experimental trivalent outer membrane vesicle vaccine were responsible for most of the bactericidal activity against strains of the otherN. meningitidisserogroups. In the case of serogroup AN. meningitidisstrains, the outer membrane antigen NadA was primarily responsible for protection. The outer membrane antigens fHbp and OpcA were also effective in removing some bactericidal activity from the sera.Keywords
This publication has 29 references indexed in Scilit:
- Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina FasoPLOS ONE, 2011
- A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle VaccinesClinical and Vaccine Immunology, 2011
- Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young AdultsClinical and Vaccine Immunology, 2010
- Characterization of an Antibody Depletion Assay for Analysis of Bactericidal Antibody SpecificityClinical and Vaccine Immunology, 2009
- Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, MenactraClinical and Vaccine Immunology, 2009
- Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal ResponseInfection and Immunity, 2009
- Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from AfricaThe Journal of Infectious Diseases, 2009
- Specificity of Subcapsular Antibody Responses in Ethiopian Patients following Disease Caused by Serogroup A MeningococciClinical and Vaccine Immunology, 2008
- Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003Emerging Infectious Diseases, 2007
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences, 2006